Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-014218
Filing Date
2024-12-23
Accepted
2024-12-23 15:36:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27722
2 filename2.txt TEXT-EXTRACT 1228
  Complete submission text file 0000000000-24-014218.txt   40297
Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Filed for) CIK: 0001662774 (see all company filings)

EIN.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283897
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)